David Reardon, MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| CUE-102 in Recurrent Glioblastoma (NCT06917885) | David Reardon, MD | 2025-07-30 |
| INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT) (NCT02977780) | David Reardon, MD | 2017-02-09 |
Track David Reardon, MD automatically
Every clearance here is in the API, with alerts when new ones post.